Ceptyr

company

About

Ceptyr is a developer of protein tyrosine phosphatase (PTP) -based therapeutics.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$11.50M
Industries
Biotechnology,Pharmaceutical
Founded date
Jan 1, 1995
Number Of Employee
11 - 50
Operating Status
Active

Ceptyr, Inc was founded to focus on developing drugs against protein tyrosine phosphatases (PTPs), a largely unexplored niche in pharmaceutical development.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$31.50M
Ceptyr has raised a total of $31.50M in funding over 2 rounds. Their latest funding was raised on Dec 23, 2002 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 23, 2002 Series Unknown $20M 1 Detail
Aug 18, 1999 Series Unknown $11.50M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Ceptyr is funded by 2 investors. ARCH Venture Partners and Falcon are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Series Unknown
Falcon Series Unknown